Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc.
  • Home
  • Our Coordinated Expression
    • Overview
    • Our Culture, Mission & Values
    • Our Commitment to Diversity & Inclusion
    • Message from BIO
  • Our People
    • Overview
    • Leadership
    • Board of Directors
    • Founders
  • Programs
    • Overview
    • SY-1425
    • SY-2101
    • SY-5609
  • Platform
    • Overview
    • What is Gene Control?
    • Publications and Abstracts
  • Patients
  • Investors & Media
  • Partners
  • Careers
  • Blog
  • Contact
Investors & Media

Investors & Media

  • Overview
  • News
    • Email Alerts
    • Press Releases
  • Events
    • IR Calendar
    • Presentations
  • Company Info
    • Profile
    • Leadership
    • Contacts
    • Analyst Coverage
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Annual Reports
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Filings
    • Quarterly Reports
    • Proxy
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor & Media Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News

  • Email Alerts
  • Press Releases
Jun 10, 2014

Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde to Dual Role as Chief Financial Officer and Chief Product Officer

Apr 2, 2014

Richard A. Young, Syros Pharmaceuticals Scientific Founder, to Open AACR Annual Meeting 2014 with Address Highlighting His Pioneering Gene Control Research

Dec 18, 2013

Syros Pharmaceuticals Announces Publication of Important Scientific Studies Related to Company's Industry-Leading Gene Control Platform

Dec 16, 2013

Dr. Nathanael Gray, a Syros Pharmaceuticals Scientific Founder, Honored with 2013 Meyenburg Cancer Research Award

Nov 21, 2013

Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors

Oct 10, 2013

Syros Pharmaceuticals Announces New Findings on Central Role of Super-Enhancers in Controlling Cell Biology and Disease

Sep 5, 2013

Syros Pharmaceuticals Appoints Vicki L. Sato, Ph.D., to Board of Directors

May 22, 2013

Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer

Apr 11, 2013

Syros Pharmaceuticals Announces Publications in Cell Related to Key Gene Control Discovery

Apr 11, 2013

Syros Pharmaceuticals Launches with $30 Million Series A Financing

RSS
    • 1...
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    © 2021 Syros Pharmaceuticals, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap
    twitter logo linkedin logo